nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/5...

Preview:

Click to see full reader

Citation preview

Recommended

Acute Hepatitis C Virus Infection: Epidemiology, Clinical ...depts.washington.edu/hepstudy/presentations/uploads/6/m1_l5acute_hep_c.pdfHepatitis web study HEPATITIS WEB STUDY H. Nina
Documents
Ombitasvir-Paritaprevir-Ritonavir (Techniviedepts.washington.edu/hepstudy/presentations/uploads/161/technivie... · 16/12/2015  · Ombitasvir-Paritaprevir-Ritonavir (Technivie)•
Documents
Treatment of Hepatitis C in Patients with Renal Insufficiencydepts.washington.edu/hepstudy/presentations/... · Hepatitis C Treatment Issues Related to Renal Disease • Hepatitis
Documents
Treatment of Chronic HCV Genotype 5 or 6depts.washington.edu/hepstudy/presentations/uploads/126/m5_l5... · • Decompensated hepatic disease • Major uncontrolled depressive illness
Documents
Treatment of HCV in Patients with HIV Coinfectiondepts.washington.edu/hepstudy/presentations/... · HCV/HIV co-infected versus HCV monoinfection (P
Documents
nfs/bronfs/uwfs/hw00/d99/nwaetc/presentations/uploads/117
Documents
nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/52/optimizedepts.washington.edu/hepstudy/presentations/uploads/52/optimize.p… · web study . Twice Daily Telaprevir for
Documents
Hepatitis C Testing Recommendationsdepts.washington.edu/hepstudy/presentations/... · Source: Rein, DB et al Ann Intern Med 2012:156:263-70. web study HCV Testing of Persons Born
Documents
Sofosbuvir in Genotypes 2 or 3 VALENCE Trialdepts.washington.edu/hepstudy/presentations/uploads/93/valence.pdf · Sofosbuvir and Ribavirin for HCV GT 2 or 3 VALENCE: Results for GT
Documents
ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,
Documents
Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/81/...Source: Manns M, et al. Lancet. 2014;384:414-26. Simeprevir + PEG + RBV in Treatment-Naïve
Documents
Addressing Psychiatric Issues Prior to HCV Treatmentdepts.washington.edu/hepstudy/presentations/uploads/35/m4_l3... · Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L,
Documents
Treatment Naïve and Treatment Experienceddepts.washington.edu/hepstudy/presentations/uploads/82/cosmos.pdf · Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase
Documents
State of the Art Therapy for HCV - University of Washingtondepts.washington.edu/hepstudy/presentations/...• Favorable clinical pharmacology profile - No food effect - No significant
Documents
Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir Viekira …depts.washington.edu/hepstudy/presentations/uploads/131/...Hepatitis web study Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir
Documents
Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/57/quest1.pdfQUEST-1 Trial QUEST-1 Trial: Features Design: Randomized, double-blind,
Documents
nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve
Documents
CFOA UwFS Protocol Code of Practice v2
Documents
Phase 3 - depts.washington.edudepts.washington.edu/hepstudy/presentations/uploads/164/ally3.pdf · Hepatitis Source: Nelson DR, et al. Hepatology 2015;61:1127-35. web study Treatment-Experienced
Documents
nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration
Documents